We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEST
14151
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$3.23K ﹤0.01%
+1,470
New +$3.67K
EXFY icon
14152
Expensify
EXFY
$210M
$3.22K ﹤0.01%
365
-135,051
-100% -$1.51M
KMDA icon
14153
CALL
Kamada
KMDA
$437M
$3.21K ﹤0.01%
+800
New +$3.53K
RLJ icon
14154
PUT
RLJ Lodging Trust
RLJ
$1.67B
$3.18K ﹤0.01%
+300
New +$3.4K
CGEM icon
14155
PUT
Cullinan Oncology
CGEM
$1.31B
$3.17K ﹤0.01%
+300
New +$3.64K
SKYT
14156
DELISTED
SkyWater Technology
SKYT
$3.16K ﹤0.01%
+445
New +$3.76K
SANA icon
14157
CALL
Sana Biotechnology
SANA
$1.06B
$3.16K ﹤0.01%
800
-10,000
-93% -$48.9K
CLLS
14158
PUT
Cellectis
CLLS
$307M
$3.15K ﹤0.01%
+1,500
New +$3.4K
RSVR
14159
Reservoir Media
RSVR
$657M
$3.14K ﹤0.01%
526
-34,879
-99% -$199K
CFFSW
14160
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$3.13K ﹤0.01%
97,628
+1,857
+2% +$122
NEUE
14161
DELISTED
NeueHealth
NEUE
$3.12K ﹤0.01%
+60
New +$4.36K
ABCM
14162
CALL
DELISTED
Abcam PLC
ABCM
$3.11K ﹤0.01%
+200
New +$3.12K
CNTA
14163
PUT
DELISTED
Centessa Pharmaceuticals
CNTA
$3.1K ﹤0.01%
+1,000
New +$3.71K
DNTH icon
14164
Dianthus Therapeutics
DNTH
$6.49B
$3.09K ﹤0.01%
489
-2,027
-81% -$35.9K
SPECW
14165
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$3.09K ﹤0.01%
155,958
+100
+0.1% +$3
UPH
14166
PUT
DELISTED
UpHealth, Inc.
UPH
$3.08K ﹤0.01%
1,890
-330
-15% -$1.28K
WEJO
14167
DELISTED
Wejo Group Limited Common Shares
WEJO
$3.08K ﹤0.01%
+6,402
New +$5.74K
CTKB icon
14168
PUT
Cytek Biosciences
CTKB
$610M
$3.06K ﹤0.01%
+300
New +$4.03K
WLMS
14169
CALL
DELISTED
Williams Industrial Services Group Inc.
WLMS
$3.06K ﹤0.01%
+3,000
New +$3.51K
RGTI icon
14170
Rigetti Computing
RGTI
$6.28B
$3.06K ﹤0.01%
+4,195
New +$6K
KRNY icon
14171
PUT
Kearny Financial
KRNY
$605M
$3.04K ﹤0.01%
+300
New +$3.01K
AUTL
14172
PUT
Autolus Therapeutics
AUTL
$572M
$3.04K ﹤0.01%
+1,600
New +$4.05K
GAN
14173
DELISTED
GAN Ltd
GAN
$3.02K ﹤0.01%
2,013
-52,923
-96% -$89K
NGM
14174
PUT
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$3.01K ﹤0.01%
600
-22,900
-97% -$144K
OGG
14175
CALL
Osisko Gold Group Inc.
OGG
$872M
$3.01K ﹤0.01%
+700
New +$3.11K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.